Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03515083

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03515083
Other papers using this trial's data
  • Prospective evaluation of the effect of smartphone electrocardiogram usage on anticoagulant medication compliance Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2022-11 DOI, PubMed 35513562

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03515083. Randomized; no masking; primary purpose supportive care. Start 2017-07-17 (actual); primary completion 2022-06-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm
Acronym
BOAT OAR
Condition
Non-valvular Atrial Fibrillation
Intervention (Device)
Alive Cor Kardia mobile electrocardiogram monitor
Lead sponsor
Saint Luke's Health System (class: other)
Collaborator
Bristol-Myers Squibb (class: industry)
Collaborator
AliveCor (class: industry)

Record details

Record id
cardio:ct-nct03515083
Content hash
dc7761b956d6e6b5eaf5c7016699a3b99a6d0bb624a089afc21103eed68b1225